Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Alessandro Armuzzi; Antonio Gasbarrini; Luisa Guidi

doi:10.1016/j.crohns.2014.01.006

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Alessandro Armuzzi
, Antonio Gasbarrini
, Luisa Guidi

Risultato della ricerca: Contributo in rivista › Articolo

45 Citazioni (Scopus)

Abstract

Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.

Lingua originale	Inglese
pagine (da-a)	852-858
Numero di pagine	7
Rivista	Journal of Crohn's and Colitis
Volume	8
DOI	https://doi.org/10.1016/j.crohns.2014.01.006
Stato di pubblicazione	Pubblicato - 2014

Keywords

Colectomy
Infliximab
Ulcerative colitis

Accesso al documento

10.1016/j.crohns.2014.01.006

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{3afe41c90a7a47158c328cea7d7eb524,

title = "Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy",

abstract = "Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.",

keywords = "Colectomy, Infliximab, Ulcerative colitis, Colectomy, Infliximab, Ulcerative colitis",

author = "Alessandro Armuzzi and Antonio Gasbarrini and Luisa Guidi",

year = "2014",

doi = "10.1016/j.crohns.2014.01.006",

language = "English",

volume = "8",

pages = "852--858",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

AU - Armuzzi, Alessandro

AU - Gasbarrini, Antonio

AU - Guidi, Luisa

PY - 2014

Y1 - 2014

N2 - Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.

AB - Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.

KW - Colectomy

KW - Infliximab

KW - Ulcerative colitis

KW - Colectomy

KW - Infliximab

KW - Ulcerative colitis

UR - http://hdl.handle.net/10807/60687

U2 - 10.1016/j.crohns.2014.01.006

DO - 10.1016/j.crohns.2014.01.006

M3 - Article

SN - 1873-9946

VL - 8

SP - 852

EP - 858

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

ER -

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo